$AIM·4

HEMISPHERX BIOPHARMA INC · Dec 14, 11:11 AM ET

HEMISPHERX BIOPHARMA INC 4

4 · HEMISPHERX BIOPHARMA INC · Filed Dec 14, 2015

Insider Transaction Report

Form 4
Period: 2015-12-09
CARTER WILLIAM A
DirectorCEO10% Owner
Transactions
  • Other

    Options

    2015-12-0973,7280 total
    Exercise: $2.71From: 2010-12-22Exp: 2020-12-22Common Stock (73,728 underlying)
  • Other

    Options

    2015-12-09150,0000 total
    Exercise: $0.25From: 2013-08-02Exp: 2023-08-02Common Stock (150,000 underlying)
  • Other

    Options

    2015-12-09320,0000 total
    Exercise: $2.60From: 2015-12-08Exp: 2024-12-08Common Stock (320,000 underlying)
  • Other

    Warrants

    2015-12-09491,1960 total
    Exercise: $0.51From: 2009-02-01Exp: 2019-02-01Common Stock (491,196 underlying)
  • Other

    Options

    2015-12-0910,0000 total
    Exercise: $4.03From: 2012-04-13Exp: 2022-04-13Common Stock (10,000 underlying)
  • Other

    Options

    2015-12-09100,0000 total
    Exercise: $0.29From: 2012-07-05Exp: 2022-06-06Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]As Section 5.1 in the 2009 Equity Incentive Plan states that there is an aggregate limitation of 3 million shares per person, these options and warrants were forfeited to comply with this limitation.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT